These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1284753)

  • 21. [Intrauterine rhesus diagnosis].
    Herrmann U
    Beitr Infusionsther; 1989; 24():214-20. PubMed ID: 2481541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experience with intrauterine transfusions for severe Rh alloimmunization in a developing country.
    Gupte SC; Lulla CP; Kulkarni SS; Korgaonkar SA; Walvekar VR; Merchant RH
    J Matern Fetal Med; 1998; 7(6):287-91. PubMed ID: 9848694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical significance of anti-D IgG screening and titer detection in 286 RhD negative pregnant women].
    Liu KL; Li N; Li BJ; Peng JY; Shu XW; Yu YY
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):185-7. PubMed ID: 19292952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current status of neonatal hemolytic disease caused by Rh incompatibility].
    Uhlig R; Menzel K
    Z Arztl Fortbild (Jena); 1986; 80(4):143-8. PubMed ID: 3087070
    [No Abstract]   [Full Text] [Related]  

  • 25. The value of different methods of amniotic fluid analysis in the diagnosis of Rh hemolytic disease (spectrophotometric and chemical determination of bilirubin, bilirubin-protein ratio, anti-Rho(D) titres).
    Dambrosio F; Della Torre L; Meroni P; Clerici-Bagozzi D
    Ann Ostet Ginecol Med Perinat; 1970 Aug-1971 Aug; 92(8):528-31. PubMed ID: 5001775
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prenatal blood transfusions for anti-D-erythroblastosis in twin pregnancies (author's transl)].
    Schultze-Mosgau H; Fischer K; Poschmann A; Berle P
    Med Klin; 1974 Jan; 69(3):94-6. PubMed ID: 4206040
    [No Abstract]   [Full Text] [Related]  

  • 27. Management of pregnancies complicated by anti-c isoimmunization.
    Hackney DN; Knudtson EJ; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2004 Jan; 103(1):24-30. PubMed ID: 14704240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Supervision of pregnant women isoimmunized with the rhesus factor. Significance and interpretation of the position of optic indices on the Liley diagram (425 cases)].
    Blanchard A; Merger R
    J Gynecol Obstet Biol Reprod (Paris); 1972 Mar; 1(2):107-31. PubMed ID: 4626034
    [No Abstract]   [Full Text] [Related]  

  • 29. Non-invasive fetal RHD and RHCE genotyping from maternal plasma in alloimmunized pregnancies.
    Hromadnikova I; Vesela K; Benesova B; Nekovarova K; Duskova D; Vlk R; Spalova I; Gerychova R; Hakenova A; Rosenbaumova Z; Vlasin P; Vlachova A; Palasek V; Roznakova E; Calda P
    Prenat Diagn; 2005 Dec; 25(12):1079-83. PubMed ID: 16231295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study of the amniotic fluid in rhesus sensitized pregnancies for the evaluation of severity of fetal hemolytic disease].
    Janev A; Aleksić M; Begić-Janeva A
    Srp Arh Celok Lek; 1986 Mar; 114(3):273-87. PubMed ID: 3147517
    [No Abstract]   [Full Text] [Related]  

  • 31. Perinatal management of fetal hemolytic disease due to Rh incompatibility combined with fetal alloimmune thrombocytopenia due to HPA-5b incompatibility.
    Schild RL; Hoch J; Plath H; Geissen C; Fahnenstich H; Dame C; Hansmann M
    Ultrasound Obstet Gynecol; 1999 Jul; 14(1):64-7. PubMed ID: 10461341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The management of hemolytic disease in the fetus and newborn.
    Bowman J
    Semin Perinatol; 1997 Feb; 21(1):39-44. PubMed ID: 9190032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of anti-Jka alloimmunization.
    Franco A; Rossi K; Krugh D; O'Shaughnessy R
    J Reprod Med; 2009 Mar; 54(3):121-5. PubMed ID: 19370894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosing hemolytic disease of the newborn.
    Brantley TA
    Clin Lab Sci; 2002; 15(3):140-3. PubMed ID: 12778961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasonography versus amniotic fluid spectral analysis: are they sensitive enough to predict neonatal complications associated with isoimmunization?
    Reece EA; Cole SW; Romero R; Gabrielli S; O'Connor TZ; Hobbins JC
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):357-60. PubMed ID: 2503793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The monocyte monolayer assay: a noninvasive technique for predicting the severity of in utero hemolysis.
    Larson PJ; Thorp JM; Miller RC; Hoffman M
    Am J Perinatol; 1995 May; 12(3):157-60. PubMed ID: 7612085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of C1q in Rhesus haemolytic disease of the newborn.
    Poorkhorsandi ME; Gupte SC
    Indian J Med Res; 1996 Sep; 104():208-12. PubMed ID: 8898479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemolytic disease of newborn.
    Narang A; Jain N
    Indian J Pediatr; 2001 Feb; 68(2):167-72. PubMed ID: 11284186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Functional evaluation of erythrocytic antibodies by photometric detection of erythrophagocytosis in the monocyte monolayer assay].
    Cassens U; Garritsen HS; Sibrowski W; Holzgreve W
    Geburtshilfe Frauenheilkd; 1996 Jun; 56(6):297-300. PubMed ID: 8766487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.